iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

Show Description +

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

Please log in to leave a comment.

More in Glaucoma

Implementing Interventional Glaucoma Treatment Protocols

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

Treatment Patterns and Patient Compliance

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; and Deborah Ristvedt, DO

Practice Assessment Results

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD

The Unmet Need for a Consensus Treatment Approach to Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Christine Funke, MD; Deborah Ristvedt, DO; and Mark Gallardo, MD